Inactive Instrument

Highlights Mesco Pharmaceuticals Limited

Equities

500274

INE839X01015

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Mesco Pharmaceuticals Widens Net Loss in Fiscal Q3	18/22/18	MT
Mesco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	17/22/17	CI
Mesco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	12/21/12	CI
Mesco Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	01/21/01	CI
Mesco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020	13/21/13	CI
Mesco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020	12/20/12	CI
Mesco Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2020	31/20/31	CI
Mesco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter Ended December 31, 2019	13/20/13	CI
Mesco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter Ended September 30, 2019	15/19/15	CI
Mesco Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2019	14/19/14	CI
Mesco Pharmaceuticals Limited Announces Audited Standalone Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2019	28/19/28	CI
Mesco Pharmaceuticals Limited Reports Unaudited Earnings Results for the Quarter and Nine Months Ended December 31, 2018	13/19/13	CI
Mesco Pharmaceuticals Ltd. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended September 30, 2018	14/18/14	CI
Mesco Pharmaceuticals Ltd Reports Unaudited Earnings Results for the First Quarter Ended June 30, 2018	14/18/14	CI
Mesco Pharmaceuticals Ltd Reports Audited Standalone Earnings Results for the Fourth Quarter and Year Ended March 31, 2018	30/18/30	CI
Mesco Pharmaceuticals Ltd. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended December 31, 2017	13/18/13	CI
Mesco Pharmaceuticals Ltd. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended September 30, 2017	14/17/14	CI
Mesco Pharmaceuticals Ltd. Announces Unaudited Earnings Results for the First Quarter Ended June 30, 2017	23/17/23	CI
Mesco Pharmaceuticals Ltd. Reports Audited Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2017	30/17/30	CI
Mesco Pharmaceuticals Ltd. Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2016	14/17/14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Mesco Pharmaceuticals Limited

Equities

500274

INE839X01015

Highlights

Filters